by Raynovich Rod | Jul 22, 2019 | Biopharmaceuticals, Macro
Update -3 …Nice biotech rally today; green screen in gene therapy and mid-cap sectors. XBI and IWM up over 1%. Update-2…Small cap reversal IWM up 1.67% to $157 level; our small cap portfolio winners: AMRN CFMS GNMK MGTX VCEL etc. but XBI still lags stuck...
by Raynovich Rod | Jul 15, 2019 | Biopharmaceuticals, Macro
Update-2 11:30a EDT Seattle Genetics (SGEN) revenues grow 30% , stock soars 15%.This is the way large cap biotech model is supposed to work-grow top line revenue.The Company is a leader in oncology with antibody-drug conjugates (ADC). ===== Update-1 Biopharma stocks...
by Raynovich Rod | Jun 27, 2019 | Biopharmaceuticals, Macro
Crazy Stealth Biotech Rally in Small Caps-Who Gave the Buy Signal? NASDAQ up 0.73%, XLV up 0.70 %. MedTech and Dx/Tools also green. IWM up 1.88% to $153.63 up 14% YTD, lagging XBI up 20.7% YTD. Volatile market for traders in small caps. It was a green screen for small...
by Raynovich Rod | Jun 24, 2019 | Biopharmaceuticals, Macro
Update-2… 6/27 2p EDT…Good day for gene therapy stocks My longs CRSP and MGTX are up. Looking better all across the screen in biopharma. Added to ABBV and XNCR yesterday. XBI up but still under $86. Update-1… Another Big Deal in Biotech in a weak...
by Raynovich Rod | Jun 10, 2019 | Biopharmaceuticals, Macro
Update-3 6/17 11:30 a EDT Pfizer (PFE) $11B Buyout of Array Pharmaceuticals (ARRY) Sparks Rally in biotech. As usual M&A brings buyers into biotech. ARRY up 56% on Pfizer $11B buyout. XBI up 3.68% to $84.46. Green screen in mid-caps, gene therapy. ==========...
by Raynovich Rod | Jun 5, 2019 | Biopharmaceuticals, Macro
Update-3…6/7- 1p EDT… Broad Tech Rally Underway Hot stocks in life science: CRSP, GILD, GSK, ILMN, VRTX, XBI up 1.56%. Update-2 …Bit of a rally at the close on the day-to-day tariff drama- now softening on Mexican tariffs; way too much obsession and...
by Raynovich Rod | May 28, 2019 | Biopharmaceuticals, Macro
Update-2 5/31 2:15 p EDT. Impossible to invest with current Tariff Headwinds-XBI down 1.24% to $79.83. NASDAQ down 1.33%. ========= Update-1 5/29… Better Tape Today Off Lows Despite 1.1% Drop in IBB and 0.93% in XBI One of our top picks from JPM was Amarin...
by Raynovich Rod | May 21, 2019 | Biopharmaceuticals, Macro
Update-2…3:15p EDT…. Mixed day-new post after close, XBI down 0.64%, IBB down 0.94%,, Dow sell-off down 0.43%. ====== Update-1 5/22… Not much follow-through from yesterday but trade-able.A horrible news week with politics, tariffs, chips and China...
by Raynovich Rod | Jan 17, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Update-2 1/21/19…Heads Up Red Futures Growth worries return-Asian Stocks down IMF Lowers Global Growth-Poor Performance for Europe Biotech rally could stall Update-1 1/20/19…XBI at $83.38 approaching November resistance at $85 Barron’s 2019...
by Raynovich Rod | Dec 13, 2018 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Macro
Update-2 After close: Market Collapses After FED Meeting-Bear Market WE all knew that the biotech sector likes looser monetary policy but this sell-off is ridiculous. The IBB is now at May 2017 levels! XBI breaks through 2018 technicals down 3.33% on downside to...